Mandate

Vinge advisor in connection with Klarna's IPO on the New York Stock Exchange

Vinge, together with Latham & Watkins, acted as advisor to bookrunners and managers in connection with the listing of Klarna, the global digital bank and provider of flexible payment solutions, on the New York Stock Exchange.

The first day of trading was September 10, 2025, and Klarna set the price for its IPO at US$40 per share, valuing the company at approximately US$15 billion.

More information about the IPO can be found here: https://www.klarna.com/international/press/klarna-lists-on-the-new-york-stock-exchange/

Vinge's team consisted mainly of Johan Larsson (Corporate), Jesper Schönbeck, Amanda Knutsson and Anna Svensson (Equity Capital Markets), Emma Stuart-Beck, Henrik Schön and David Flodin (Regulatory) and Victor Ericsson, Erik Kochbati and Marcus Svärd (Tax).

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026